Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups.

[1]  David J Henderson-Smart,et al.  Methylxanthine treatment for apnoea in preterm infants. , 2010, The Cochrane database of systematic reviews.

[2]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[3]  L. Doyle,et al.  Long-term effects of caffeine therapy for apnea of prematurity. , 2007, The New England journal of medicine.

[4]  L. Doyle,et al.  Caffeine therapy for apnea of prematurity. , 2006, The New England journal of medicine.

[5]  S. Lagakos.  The challenge of subgroup analyses--reporting without distorting. , 2006, The New England journal of medicine.

[6]  V. Vallon,et al.  Requirement of Intact Adenosine A1 Receptors for the Diuretic and Natriuretic Action of the Methylxanthines Theophylline and Caffeine , 2005, Journal of Pharmacology and Experimental Therapeutics.

[7]  P. Davis,et al.  Prophylactic methylxanthines for extubation in preterm infants. , 2003, The Cochrane database of systematic reviews.

[8]  P. Davis,et al.  Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation. , 2000, The Cochrane database of systematic reviews.

[9]  K. Fong,et al.  The Effect of Aminophylline on the Excursions of the Diaphragm in Preterm Neonates: A Randomized Double‐Blind Controlled Study , 1991, Acta paediatrica Scandinavica.

[10]  J. Dirgo,et al.  Aminophylline increases cerebral metabolic rate and decreases anoxic survival in young mice. , 1978, Science.

[11]  D. Henderson-smart,et al.  Prophylactic methylxanthine for preventing of apnea in preterm infants. , 2000, The Cochrane database of systematic reviews.

[12]  F. Simons,et al.  Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. , 1978, The Journal of pediatrics.